Latest Updates

Lupin launches Duloxetine 40mg delayed-release capsules in US

Read more

Glenmark’s novel monoclonal antibody GBR 830 to enter phase II clinical studies

Read more

Bosch Rexroth appoints Hans Bangert as MD

Read more

India to introduce injectable polio vaccine from November

Read more

Sandoz launches Zarxio, the first biosimilar in US

Read more

DBT to celebrate its 30th Foundation Day in February 2016

Read more

First Absorb trial in Japan meets primary endpoint

Read more

Suven Life Sciences’ NCE SUVN-D4010 commences phase I trial in US

Read more

Fermenta Biotech ties up with Vitamin Angels

Read more

Valeant picks up AstraZeneca psoriasis drug after Amgen exit

Read more